同源康医药-B（股票代码：02410）于2026年7月2日披露了2026年6月股份变动月报表，内容涉及2026年6月1日至6月30日期间的股本变动及公众持股情况。公告显示，公司截至6月末的已发行普通股总数（H股）为380,065,818股，较上月无变动，库存股份为0股，注册股本维持人民币380,065,818元。
公告指出，当月并未发生新增发行、股份购回、注销或回购后以库存形式保存等事项，也无股份期权及股权激励计划的授出、行使或变动情况。公司确认满足相关上市规则规定的最低公众持股量要求，股权结构持续保持稳定。
上述信息由执行董事、董事长兼总裁吴豫生于公告中签署。公司表示，将继续依照香港联合交易所有限公司《上市规则》及相关法律法规履行信息披露义务。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.